Pre-IPO Employee Stock Ownership Plans: Designing Equity Incentives for a US Listing

The window for PRC-based companies to list in the US via traditional IPOs has narrowed, yet the pipeline for 2025-2026 remains robust, with at least 30 Chinese issuers confidentially filing with the SEC as of Q1 2025, according to data from Renaissance Capital. This resurgence, however, comes with heightened scrutiny from both the SEC and the PRC’s CSRC under the revised Measures for the Administration of Overseas Securities Offering and Listing by Domestic Companies (effective 31 March 2023). For CFOs and company secretaries, the most critical pre-listing workstream is no longer just financial due diligence or legal structuring—it is the design and implementation of a pre-IPO Employee Stock Ownership Plan (ESOP). A poorly structured ESOP can trigger material misstatements in the F-1 registration statement, create adverse tax consequences for employees under PRC Individual Income Tax Law (IIT), and, most damagingly, lead to SEC comment letters that delay the entire offering. This article provides a technical roadmap for designing equity incentives that survive SEC review, comply with PRC foreign exchange controls (SAFE Circular 37 and 7), and align with NASDAQ/NYSE corporate governance standards, drawing on the latest HKEX guidance as a comparative benchmark.

The SEC’s New Focus on ESOP Dilution and Fair Value

The SEC’s Division of Corporation Finance has, since late 2024, intensified its review of pre-IPO ESOPs, specifically targeting the fair value determination of share-based compensation granted within the 12 months preceding the initial confidential filing. This shift is directly tied to the SEC’s updated guidance on the application of ASC 718 (formerly FAS 123R), which requires issuers to demonstrate that the grant-date fair value of options or restricted share units (RSUs) was not artificially depressed to minimise compensation expense on the income statement.

Fair Value Methodologies Under Scrutiny

The SEC now expects a clear, documented rationale for the valuation methodology used, particularly for companies that lack a public trading market. The most common approach—the Discounted Cash Flow (DCF) method—must be supported by a contemporaneous valuation report from an independent third-party appraiser, typically a Big Four firm or a specialist like Duff & Phelps. The SEC will probe for a “valuation step-up” pattern: if an issuer grants options at HKD 1.00 per share six months pre-IPO, but the IPO price is HKD 20.00, the SEC will issue a comment letter demanding an explanation for the 1,900% differential. In the 2024 SEC comment letter to a Cayman-incorporated Chinese EV maker, the staff asked for “a detailed analysis of the material assumptions used in the DCF model, including the risk-free rate, expected volatility, and the probability of an IPO at each grant date.” Issuers must retain all board resolutions and valuation committee minutes that approve each grant, with the fair value calculation explicitly stated.

The “Look-Back” Provision and Option Repricing

A second area of SEC focus is the “look-back” provision in ESOPs that allows participants to reprice options at the IPO price after listing. While common in the US private company context, the SEC now views this as a modification of the original grant, requiring a new fair value measurement under ASC 718. This can retroactively increase compensation expense by 30% to 50%, depending on the stock price trajectory. For Hong Kong-based issuers listing on NASDAQ, this is a direct conflict with HKEX Listing Rule 17.03, which prohibits any repricing of options without prior shareholder approval. To avoid a dual compliance headache, the recommended structure is a fixed-price plan with no repricing provisions, or alternatively, a performance-based vesting schedule tied to the IPO itself, which the SEC has accepted in recent filings.

PRC Regulatory Compliance: SAFE, CSRC, and IIT Traps

For PRC-domiciled or PRC-operating companies—which constitute the majority of Hong Kong-headquartered US listings via a Cayman or BVI topco—the ESOP must navigate three distinct regulatory layers: the CSRC’s overseas listing filing, SAFE’s foreign exchange registration, and the PRC IIT treatment.

CSRC Filing Requirements for ESOPs

Under the CSRC’s Trial Measures (2023), any ESOP that involves shares of an overseas-listed entity must be disclosed in the prospectus and filed with the CSRC within three business days of the SEC’s effectiveness. The filing must include a list of all ESOP participants who are PRC residents, the number of shares allocated, and the vesting schedule. Failure to file can result in a suspension of the offering. In a 2024 case involving a Beijing-based AI company, the CSRC issued a stop-work order because the ESOP included 47 PRC-resident employees who had not completed the SAFE 37 registration, delaying the IPO by four months. The CSRC’s threshold is clear: any equity incentive granted to a PRC resident, whether via options, RSUs, or restricted stock, requires a CSRC filing if the underlying shares are listed overseas.

SAFE Circular 37 and 7 Registration

The State Administration of Foreign Exchange (SAFE) regulations are the most operationally complex. Under SAFE Circular 37 (2014), any PRC resident who receives shares or options in an overseas special purpose vehicle (SPV) must register with the local SAFE branch within 30 days of the grant. For pre-IPO ESOPs, the typical approach is a “centralised registration” where the company, through its PRC subsidiary, files a single application covering all eligible employees. However, SAFE Circular 7 (2015) adds a layer of reporting for the repatriation of proceeds upon exercise or sale. The practical challenge is timing: the registration process can take 8-12 weeks, and the SAFE bureau in Beijing or Shanghai often requires a notarised copy of the ESOP plan document, the board resolution, and the employee’s PRC ID card. To avoid a last-minute bottleneck, the ESOP grant date should be set at least six months before the expected IPO date to allow for SAFE processing.

PRC IIT Treatment of Share-Based Compensation

The PRC IIT law treats income from the exercise of stock options as “salary income” taxed at progressive rates up to 45%. However, a preferential tax treatment is available if the options meet the conditions under Cai Shui [2005] No. 35: the options must be granted to senior management or technical core staff, the exercise price must not be less than the fair market value at grant, and the employee must hold the shares for at least one year post-exercise. For RSUs, the PRC tax treatment is less favourable: the full fair market value at vesting is treated as salary income, with no deferral. The optimal structure for PRC employees is therefore options rather than RSUs, with a one-year holding period to qualify for the preferential 20% flat rate on capital gains upon sale. This requires careful drafting of the ESOP plan document to explicitly state the holding period and the exercise price methodology.

Structuring the ESOP for NASDAQ/NYSE Governance

The corporate governance requirements of NASDAQ and NYSE impose specific constraints on ESOP design that differ materially from HKEX Main Board rules. The key divergence is in shareholder approval thresholds and the treatment of “dilutive” plans.

Shareholder Approval Thresholds Under NASDAQ Rule 5635(c)

NASDAQ Listing Rule 5635(c) requires shareholder approval for any equity compensation plan that would result in a dilution of more than 20% of the outstanding shares. This is a bright-line test. For a pre-IPO company with 100 million shares outstanding, an ESOP reserving 25 million shares (25% dilution) would trigger a mandatory shareholder vote. The typical Hong Kong practice of reserving 10-15% of the post-IPO share capital for an ESOP (per HKEX guidance) is well within this limit. However, if the ESOP includes an “evergreen” provision that automatically increases the pool annually, the SEC and NASDAQ will treat the entire potential dilution as requiring shareholder approval. The safe harbour is to fix the maximum number of shares in the plan at the time of IPO approval, with no automatic top-up.

Vesting Schedules and Performance Conditions

NYSE’s Listed Company Manual Section 303A.08 requires that compensation committees be composed entirely of independent directors. For pre-IPO companies, this is often impossible, so the SEC permits a “phase-in” period of one year post-listing. During this period, the board (which may include founders and VCs) can approve ESOP grants, but the SEC will scrutinise any grants made within 90 days of the IPO for potential “spring-loading”—granting options just before material positive news. The recommended vesting schedule is a four-year graded vesting with a one-year cliff, which is market-standard for US-listed tech companies. Performance-based vesting tied to revenue targets or EBITDA milestones is increasingly common and can reduce compensation expense if the targets are not met. However, the SEC requires that performance conditions be objectively measurable and disclosed in the proxy statement.

Anti-Dilution Protections and Adjustments

Both NASDAQ and NYSE require that the ESOP include anti-dilution provisions for stock splits, reverse splits, and dividends. The standard language follows the Merrill Lynch precedent: a proportional adjustment to the exercise price and number of shares. A critical detail for Hong Kong-based issuers is the treatment of a “spin-off” of a subsidiary. If the listing vehicle (Cayman topco) spins off its PRC operating subsidiary as a separate listed entity, the ESOP must provide for a “substitute award” in the spin-off entity. Without this clause, the SEC will deem the original options as cancelled, triggering a taxable event for employees. The ESOP trust deed should explicitly authorise the board to make equitable adjustments in the event of a corporate restructuring.

Tax and Accounting Implications Under US GAAP and IFRS

The accounting treatment of share-based compensation under US GAAP (ASC 718) versus IFRS 2 has direct P&L implications that CFOs must model before selecting the listing venue.

ASC 718 vs. IFRS 2: The Valuation Divergence

Under ASC 718, options are valued using a lattice model (e.g., binomial) or the Black-Scholes-Merton formula, with the expected term being the key input. For a pre-IPO company, the SEC expects the expected term to be based on the “simplified method” (the midpoint of the vesting period and the contractual term) for the first two years post-grant. Under IFRS 2, which is used by most Hong Kong-listed companies, the valuation methodology is identical, but the IFRS 2 treatment of forfeitures is different: ASC 718 requires an estimate of forfeitures at grant date and a true-up each period, while IFRS 2 requires a full expense recognition unless forfeiture is virtually certain. For a pre-IPO ESOP with high employee turnover, this can result in a 15-20% higher expense under IFRS 2. For a company listing in the US, the SEC mandates ASC 718, so the ESOP must be designed with a conservative forfeiture estimate to avoid a material misstatement.

Deferred Tax Assets and the Valuation Allowance

A pre-IPO ESOP generates a deferred tax asset (DTA) for the company, representing the future tax deduction when options are exercised. Under US GAAP, this DTA must be evaluated for a valuation allowance if it is “more likely than not” that the company will not have sufficient taxable income to utilise it. For a loss-making pre-IPO company, this often results in a full valuation allowance, meaning the DTA provides no balance sheet benefit. However, upon exercise, the company receives a cash tax deduction equal to the intrinsic value of the options, which can be substantial. The SEC requires that this “windfall” tax benefit be recorded in additional paid-in capital (APIC), not the income statement, under ASU 2016-09. CFOs must ensure that the ESOP trust is structured to allow for the timely exercise and sale of shares to generate the cash tax benefit, which is particularly important for PRC subsidiaries that may face withholding tax obligations.

Closing Section: Three Actionable Takeaways

1. File the ESOP plan with the CSRC at least 90 days before the SEC confidential filing, and ensure all PRC-resident participants complete SAFE 37 registration before the grant date to avoid a regulatory hold on the IPO.
2. Use a fixed-price option plan with a four-year graded vesting and no repricing provisions to avoid SEC comment letters on fair value and to comply with NASDAQ Rule 5635(c) on shareholder approval thresholds.
3. Retain an independent third-party valuation report for every grant made within 12 months of the IPO, documenting the DCF assumptions and the probability of an IPO, to defend against SEC scrutiny under ASC 718.
4. Structure the ESOP for PRC employees as options rather than RSUs to qualify for the preferential 20% capital gains tax rate under Cai Shui [2005] No. 35, and include a mandatory one-year holding period in the plan document.
5. Model the deferred tax asset under ASC 718 with a conservative forfeiture estimate, and plan for a full valuation allowance if the company is loss-making, to avoid a material misstatement in the F-1.